New triple antiviral drug combination shows early promise for treating COVID-19 in phase 2 randomized trial
A two-week system of antiviral remedy with interferon beta-1b, in addition lopinavir-ritonavir and ribavirin, started
A two-week system of antiviral remedy with interferon beta-1b, in addition lopinavir-ritonavir and ribavirin, started